SpaceX Isn't Rocket Lab's Biggest Threat Now -- Blue Origin Is

NASA awarded Blue Origin an estimated $700 million contract to deliver a Mars Telecommunications Orbiter by Dec. 31, 2028, prompting Rocket Lab to file a GAO protest on Sept. 11 alleging the selection violated congressional eligibility criteria. A GAO decision is expected roughly 100 days after the protest filing; a prolonged dispute could jeopardize the 2028 Mars launch window and delay the program by 26 months. The loss follows Rocket Lab's missed opportunity on a proposed $4 billion Mars sample-return mission, but its pending $8 billion acquisition of Iridium—adding $884 million of annual revenue to Rocket Lab's $769 million—could make the combined company profitable and free-cash-flow positive after closing next year.

Analysis

The near-term equity implication is asymmetric for RKLB: the protest itself is unlikely to create meaningful value unless it produces a corrective-action order or a re-compete, while it can reinforce investor concerns that deep-space revenue remains lumpy and politically exposed. A favorable GAO outcome within roughly 100 days would be a sentiment catalyst, but the more investable read-through is that a prolonged dispute could impair program timing for every bidder; that reduces the value of a potential win because fixed-price deep-space work becomes less attractive when schedule risk rises. Blue Origin is private, leaving RKLB as the only liquid public vehicle for the headline despite its limited direct economic exposure.

The more material valuation issue is the proposed IRDM combination, not the contested award. If it closes on stated terms, RKLB shifts from a pure execution/multiple story toward an integrated space-infrastructure model with recurring service revenue, potentially lowering its cost of capital and supporting a higher revenue-quality multiple. But the claim of immediate profitability and free-cash-flow positivity needs independent confirmation against acquisition financing, purchase accounting, interest expense, integration costs, and any IRDM shareholder/redemption mechanics; leverage could offset much of the purported FCF benefit for 12-24 months.

Contrarian view: consensus may overreact to the Mars loss while underpricing the concentration risk embedded in the acquisition thesis. Government deep-space awards are strategically useful but too episodic to underwrite the core model; durable upside requires RKLB to demonstrate that satellite manufacturing, launch, and the acquired communications base produce cross-sell and margin expansion. Conversely, an adverse legal result may be a modest positive if management rapidly reallocates bidding, engineering, and working-capital capacity to higher-return defense and commercial programs.

Key Decisions for Investors

• Maintain RKLB as a watch-list long rather than add on protest headlines; initiate only after disclosure of definitive IRDM financing and pro forma leverage/FCF guidance. Target a 6-12 month rerating from recurring-revenue mix improvement, but exit or reassess if pro forma net leverage exceeds management's stated path or FY2027 FCF guidance excludes material integration and interest costs.
• For event-driven books, monitor the IRDM deal spread versus the stated consideration rather than take directional IRDM exposure immediately. A widening spread after merger approval can offer a defined closing trade only if regulatory approvals, financing commitments, exchange ratio/cash consideration, and expected close date are independently verified; principal risk is RKLB financing repricing or a delayed close.
• Do not short RKLB solely on an unfavorable GAO ruling: the contract is too small relative to the strategic and financial impact of the pending acquisition. A more attractive downside setup would be a post-deal long IRDM-equivalent cash-flow asset/short RKLB residual-growth premium trade if RKLB rallies materially before management quantifies synergies, leverage, and integration costs.
• Set a catalyst alert for the GAO decision window and for any NASA stop-work, corrective-action, or re-compete notice. A re-compete is bullish for RKLB sentiment but should not be modeled as revenue until NASA confirms revised award timing and economics; a federal-court escalation would instead increase schedule risk and favor trimming event-driven exposure.